Dynavax Technologies Corporation Stock price
Equities
DVAX
US2681582019
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.37 USD | -0.32% | +1.69% | -11.55% |
Feb. 23 | Dynavax Technologies Reports Breakeven Q4 Earnings, Lower Revenue | MT |
Feb. 22 | Transcript : Dynavax Technologies Corporation, Q4 2023 Earnings Call, Feb 22, 2024 |
Financials (USD)
Sales 2024 * | 294M | Sales 2025 * | 357M | Capitalization | 1.62B |
---|---|---|---|---|---|
Net income 2024 * | 33M | Net income 2025 * | 62M | EV / Sales 2024 * | 3.55 x |
Net cash position 2024 * | 577M | Net cash position 2025 * | 714M | EV / Sales 2025 * | 2.54 x |
P/E ratio 2024 * |
48.7
x | P/E ratio 2025 * |
29.1
x | Employees | 408 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.71% |
Latest transcript on Dynavax Technologies Corporation
1 day | +0.32% | ||
1 week | +2.56% | ||
Current month | -2.05% | ||
1 month | -4.46% | ||
3 months | -12.17% | ||
6 months | -14.35% | ||
Current year | -11.23% |
Managers | Title | Age | Since |
---|---|---|---|
Ryan Spencer
CEO | Chief Executive Officer | 46 | 04-12-31 |
Kelly MacDonald
DFI | Director of Finance/CFO | 40 | 21-02-28 |
David Novack
PSD | President | 62 | 13-03-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Francis Cano
BRD | Director/Board Member | 79 | 09-11-02 |
Peggy Phillips
BRD | Director/Board Member | 70 | 06-07-31 |
Dan Kisner
BRD | Director/Board Member | 77 | 10-07-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.28% | 26 M€ | -0.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 12.36 | -0.36% | 36 611 |
24-03-27 | 12.41 | +0.32% | 829,944 |
24-03-26 | 12.37 | -1.04% | 1,066,249 |
24-03-25 | 12.5 | +1.71% | 1,013,333 |
24-03-22 | 12.29 | +1.07% | 1,006,700 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.23% | 1.62B | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.92% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |